Skip to Main Content

Aimee Talleur, MD

Associate Member, St. Jude Faculty

Fellowship Director, BMTCT Fellowship Program

On this page:

Contact Information

Aimee Talleur, MD

Bone Marrow Transplant & Cellular Therapy

MS 1130, Room I3309

St. Jude Children's Research Hospital

262 Danny Thomas Place

MemphisTN 28105-3678

Education

BA - Union College, Schenectady, NY MD - State University of New York Upstate Medical University, Syracuse, NY Pediatric Residency – Children’s National Medical Center, Washington DC Pediatric Hematology-Oncology Fellowship – St. Jude Children’s Research Hospital Pediatric Bone Marrow Transplantation and Cellular Therapy Fellowship - St. Jude Children’s Research Hospital

Research Interests

  • Cancer immunotherapy
  • Adoptive cell therapy
  • Clinical investigation of chimeric antigen receptor therapies

Clinical Trials

Recruiting
1922CAR: Cell Therapy for Acute Lymphoblastic Leukemia

Study goal:

To study the side effects of CAR T cells, find the safest and most effective dose, see how long the CAR T cells last in the body, and find out how well the therapy works in people with refractory or relapsed acute lymphoblastic leukemia.

Recruiting
MEMCAR19: Allogeneic CAR T-Cell Therapy for Relapsed/Refractory CD19-Positive Leukemia

Study goal:

The main goal of this study is to learn the largest dose of memory CAR T cells that can be safely given. Researchers also want to learn about the way memory CAR T cells act in the body and how effectively they treat this type of cancer.

Published results
SJCAR19: CAR T-Cell Therapy for Children and Young Adults with Acute Lymphoblastic Leukemia

Study goal:

1) To determine the maximum tolerated dose (MTD) and characterize the safety profile and dose-limiting toxicities (DLTs) of treatment with SJCAR19 in these patients (Phase I); 2) to evaluate the complete response rates of SJCAR19 in these patients (Phase II)

St. Jude Publications